KazakhTenders notice for Safety and Efficacy of Amyloid-Beta Directed Antibody Therapy in Mild Cognitive Impairment and Dementia with Evidence of Lewy Body Dementia and Amyloid-Beta Pathology (U01 - Clinical Trial Required). The reference ID of the tender is 101557998 and it is closing on 24 Jan 2025.
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINFresh and verified Tenders from Kazakh. Find, search and filter Tenders/Call for bids/RFIs/RFPs/RFQs/Auctions published by the government, public sector undertakings (PSUs) and private entities.
Fill out the form below and you will receive a call from us within 24 hours.
Get FREE SAMPLE TENDERS from Kazakh in your email inbox.
Copyright © 2014-2024 KazakhTenders.com. All Rights Reserved.